13F filer · CIK 1179392 ↗

Two Sigma

You are looking at Q4 2022. See the latest, Q2 2026 →

Reported value

$31.85B

+8.2% on the quarter before

Positions

2,767

827 new · 492 sold out

Top 10

7.9%

of the value

Est. gain

+$1.26B

on stocks held all quarter

Est. return

+7.2%

on those stocks since Q3 2022

Filed

Feb 14, 2023

On SEC EDGAR ↗

Positions as of Dec 31, 2022, from Two Sigma's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 17% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2022. Striped tiles are options.

Invesco Qqq Tr0.9%
Visa Inc.0.8%
Gilead Sciences Inc0.8%
Pg&E Corp0.8%
AMD0.8%
Union Pac Corp0.8%
Amgen Inc0.8%
Mcdonalds Corp0.8%
Alphabet0.8%PayPal0.8%Amazon0.7%
Medtronic Plc0.7%
Johnson & Johnson0.7%
Edwards Lifesciences Corp0.7%
Cisco0.7%
Lockheed Martin Corp0.7%
Cme Group Inc0.7%
Zoom0.7%
Csx Corp0.7%
Citigroup Inc0.7%
Adobe0.6%DocuSign0.6%Airbnb0.6%
Us Bancorp Del0.6%

Largest buys

Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Amazon~$231.5MAdded · 0.0% → 0.7%+2,756,234 shares
  2. PayPal~$210.6MAdded · 0.1% → 0.8%+2,957,532 shares
  3. Amerisourcebergen Corp~$173.5MAdded · 0.0% → 0.6%+1,046,829 shares
  4. AMD~$165.4MAdded · 0.3% → 0.8%+2,553,323 shares
  5. Yum Brands Inc~$152.0MNew · 0.0% → 0.5%+1,187,068 shares
  6. Baxter Intl Inc~$149.7MAdded · 0.1% → 0.5%+2,936,599 shares
  7. Tesla~$145.2MAdded · 0.3% → 0.6%+1,178,765 shares
  8. Edwards Lifesciences Corp~$143.4MAdded · 0.3% → 0.7%+1,921,433 shares
  9. Ishares Tr~$139.4MNew · 0.0% → 0.4%+1,400,000 shares
  10. Salesforce~$134.4MAdded · 0.2% → 0.6%+1,013,787 shares

Largest sells

Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. SPDR S&P 500 ETF Tr~$291.5MCut · 1.2% → 0.3%−762,211 shares
  2. Gsk Plc~$231.2MCut · 0.7% → 0.1%−6,579,584 shares
  3. Jpmorgan Chase & Co~$225.7MSold out · 0.8% → 0.0%−2,159,540 shares
  4. Procter And Gamble Co~$218.8MCut · 0.8% → 0.2%−1,443,813 shares
  5. Intuitive Surgical~$198.4MCut · 0.5% → 0.0%−747,825 shares
  6. Accenture Plc Ireland~$185.1MCut · 0.7% → 0.0%−693,840 shares
  7. Nike Inc~$178.8MSold out · 0.6% → 0.0%−2,151,470 shares
  8. Abbott Labs~$171.3MCut · 0.5% → 0.0%−1,560,560 shares
  9. Comcast Corp New~$158.2MCut · 0.6% → 0.1%−4,523,067 shares
  10. Broadcom~$156.1MSold out · 0.5% → 0.0%−351,529 shares

Holdings

As of Dec 31, 2022. Changes are in shares against Sep 30, 2022, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
Invesco Qqq TrUNIT SER 1 · shares −15% · price −0.4%0.94%$300.0M−$1.1M
Visa Inc.COM CL A · shares −13% · price +16.9%0.80%$253.9M+$36.8M
Gilead Sciences IncCOM · shares −17% · price +39.2%0.80%$253.8M+$71.4M
Pg&E CorpUNIT 08/16/2023 · shares +7.4% · price +26.3%0.78%$250.0M+$48.4M
AMDCOM · shares +203% · price +2.2%0.78%$246.9M+$1.8M
Union Pac CorpCOM · shares +18% · price +6.3%0.77%$245.7M+$12.3M
Amgen IncCOM · shares −0.2% · price +16.5%0.77%$243.7M+$34.6M
Mcdonalds CorpCOM · shares +84% · price +14.2%0.76%$242.1M+$16.4M
AlphabetCAP STK CL A · shares +25% · price −7.8%0.76%$241.7M−$16.3M
PayPalCOM · shares +738% · price −17.3%0.75%$239.2M−$6.0M
AmazonCOM · shares +3,298% · price −25.7%0.75%$238.5M−$2.4M
Medtronic PlcSHS · shares +33% · price −3.8%0.74%$236.2M−$6.9M
Johnson & JohnsonCOM · shares +0.3% · price +8.1%0.74%$235.2M+$17.6M
Edwards Lifesciences CorpCOM · shares +168% · price −9.7%0.72%$228.9M−$9.2M
CiscoCOM · shares −18% · price +19.1%0.70%$221.5M+$35.5M
Lockheed Martin CorpCOM · shares −8.0% · price +25.9%0.68%$216.8M+$44.7M
Cme Group IncCOM · shares +116% · price −5.1%0.68%$216.5M−$5.3M
ZoomCL A · shares +67% · price −7.9%0.66%$210.6M−$10.9M
Csx CorpCOM · shares −11% · price +16.3%0.65%$208.0M+$29.1M
Citigroup IncCOM NEW · shares +8.1% · price +8.5%0.65%$207.7M+$15.1M
AdobeCOM · shares −30% · price +22.3%0.65%$206.0M+$37.5M
DocuSignCOM · shares +10% · price +3.6%0.63%$200.1M+$6.4M
AirbnbCOM CL A · shares +11% · price −18.6%0.62%$198.8M−$41.1M
Us Bancorp DelCOM NEW · shares +47% · price +8.2%0.62%$197.1M+$10.1M
Kroger CoCOM · shares +29% · price +1.9%0.62%$196.3M+$2.8M
Total · 2,767 positions100%$31.85B+$1.26B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2022 to Q4 2022: 1,881 stocks held throughout, up $1.26B (+7.2%).

  1. Gilead Sciences Inc+$71.4M+39%
  2. Pg&E Corp+$48.4M+26%
  3. Lockheed Martin Corp+$44.7M+26%
  4. Adobe+$37.5M+22%
  5. Visa Inc.+$36.8M+17%
  6. Horizon Therapeutics Pub L1:24 split−$19.1M−92%
  7. Plug Power Inc−$27.5M−41%
  8. Twilio−$27.7M−29%
  9. Airbnb−$41.1M−19%
  10. Tesla−$46.0M−54%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 16 splits read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$200.00B$100.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$138.12B+11%SEC ↗
Q1 2026$123.93B+75%SEC ↗
Q4 2025$70.90B+6%SEC ↗
Q3 2025$67.17B+19%SEC ↗
Q2 2025$56.47B+21%SEC ↗
Q1 2025$46.79B+2%SEC ↗
Q4 2024$45.85B+0%SEC ↗
Q3 2024$45.63B+4%SEC ↗
Q2 2024$43.90B+3%SEC ↗
Q1 2024$42.61B−2%SEC ↗
Q4 2023$43.54B+17%SEC ↗
Q3 2023$37.17B−7%SEC ↗
Q2 2023$39.87B+14%SEC ↗
Q1 2023$34.99B+10%SEC ↗
Q4 2022$31.85B+8%SEC ↗
Q3 2022$29.43B−3%SEC ↗
Q2 2022$30.30B−11%SEC ↗
Q1 2022$33.88B−28%SEC ↗
Q4 2021$46.81B+5%SEC ↗
Q3 2021$44.75B+1%SEC ↗
Q2 2021$44.08B+15%SEC ↗
Q1 2021$38.44B+10%SEC ↗
Q4 2020$34.85B+24%SEC ↗
Q3 2020$28.17B+40%SEC ↗
Q2 2020$20.19B+64%SEC ↗
Q1 2020$12.28B−63%SEC ↗
Q4 2019$33.24B+12%SEC ↗
Q3 2019$29.72B−1%SEC ↗
Q2 2019$29.90B−3%SEC ↗
Q1 2019$30.85B+21%SEC ↗
Q4 2018$25.54B−30%SEC ↗
Q3 2018$36.69B+9%SEC ↗
Q2 2018$33.54B+12%SEC ↗
Q1 2018$30.04B−2%SEC ↗
Q4 2017$30.72B+9%SEC ↗
Q3 2017$28.21B+2%SEC ↗
Q2 2017$27.64B−7%SEC ↗
Q1 2017$29.70B+14%SEC ↗
Q4 2016$26.08B−5%SEC ↗
Q3 2016$27.59B+18%SEC ↗
Q2 2016$23.29B+11%SEC ↗
Q1 2016$20.99BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.